COVID-19 test strip

for antigensSARS-COV-2nasal

The kit is intended for symptomatic individuals within first seven days from onset of the symptoms. It is for the qualitative detection of SARS-associated corona virus (SARS-CoV-2) antigens and Influenza A&B antigens from human nasal swab to assist in the diagnosis of corona virus (Covid-19) infection. It is recommended to combine results from this test with further clinical data to confirm the diagnosis. TYPES OF SPECIMENS Human nasal swab. PRINCIPLE It is based on a sandwich method immunochromatographic assay for the highly sensitive detection of COVID-19 nucleoprotein and Influenza A&B in human nasal providing with an invisible test area (T) and control area (C). Then a specimen is released into the tube buffer, the liquid laterally migrates along the test strip. If sufficient COVID-19 and Influenza A&B antigen is present in the specimen, a visible line of test area (T) appears. As process control, a colored band shall appear in the control area (C) to confirm that sufficient specimen has been absorbed. The test result is visually interpreted after 15 minutes basing on the presence or absence of visually recognizable colored lines. The strip signals could last 10 days for double check if necessary. REAGENTS AND MATERIALS PROVIDED Each kit contains buffer, swab and an instruction manual.